Potentiating of lipid-lowering activity of clofibrate by combining with low doses of 3-pyridylcarbinol in rats.
D000818:Animals; D010367:Arachis; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary / Q000008:administration & dosage; D002994:Clofibrate / Q000494:pharmacology*; D004032:Diet; D004041:Dietary Fats / Q000008:administration & dosage; D004305:Dose-Response Relationship, Drug; D006937:Hypercholesterolemia / Q000097:blood / Q000139:chemically induced / Q000378:metabolism; D050356:Lipid Metabolism; D008053:Lipid Mobilization; D008055:Lipids / Q000097:blood*; D008297:Male; D000432:Methanol / Q000031:analogs & derivatives / Q000494:pharmacology*; D009821:Oils / Q000008:administration & dosage; D011441:Propylthiouracil / Q000009:adverse effects; D051381:Rats; D014280:Triglycerides / Q000097:blood
D002791:Cholesterol, Dietary; D004041:Dietary Fats; D008055:Lipids; D009821:Oils; D014280:Triglycerides; D011441:Propylthiouracil; D002784:Cholesterol; D002994:Clofibrate; D000432:Methanol